Scienture Holdings, Inc. announced entering into a securities purchase agreement with institutional investors.
The agreement involves the purchase of 3,225,000 shares of common stock at $1.20 per share.
The gross proceeds from the offering are expected to be around $3.9 million before deducting expenses.
Offering Details
3,225,000 shares of common stock at $1.20 per share
Gross Proceeds
Approximately $3.9 million before expenses
Offering Close Date
Expected on August 15, 2025, subject to customary conditions
- Maxim Group LLC is the sole placement agent for the offering.
- The offering is being made under an effective shelf registration statement on Form S-3.
This move will provide Scienture Holdings, Inc. with necessary funds to further its pharmaceutical operations and product development.